635 results on '"Schnitzer, Thomas J"'
Search Results
2. Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability
3. A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip
4. Does sex affect the efficacy of systemic pharmacological treatments of pain in knee osteoarthritis? A systematic review
5. A Two-Step, Trajectory-Focused, Analytics Approach to Attempt Prediction of Analgesic Response in Patients with Moderate-to-Severe Osteoarthritis
6. Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial
7. Bone Mineral Loss at the Distal Femur and Proximal Tibia Following Spinal Cord Injury in Men and Women
8. Characterizing 16-Week Responder Profiles Using Group-Based Trajectory Modeling in Over 4300 Clinical Trial Participants Receiving Pharmaceutical Treatment for Moderate to Severe Osteoarthritis
9. Monthly treatment with romosozumab for one year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury
10. Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States
11. Factors associated with physician-reported treatment status of patients with osteoarthritis pain
12. Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.
13. Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis
14. Sex-Specific Pharmacotherapy for Back Pain: A Proof-of-Concept Randomized Trial
15. Bone loss at the knee after spinal cord injury: Radiographic imaging, fracture risk, and treatment
16. Contributors
17. Psychosocial, Functional, and Emotional Correlates of Long-Term Opioid Use in Patients with Chronic Back Pain: A Cross-Sectional Case–Control Study
18. Monthly treatment with romosozumab for 1 year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury.
19. General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials
20. Neuropsychology of chronic back pain managed with long-term opioid use
21. Stiffness and Strength Predictions From Finite Element Models of the Knee are Associated with Lower-Limb Fractures After Spinal Cord Injury
22. Serum Keratan Sulfate Concentration as a Measure of the Catabolism of Cartilage Proteoglycans
23. Hippocampal morphology mediates biased memories of chronic pain
24. Hippocampus shape deformation: a potential diagnostic biomarker for chronic back pain in women
25. Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density
26. Subcortical brain anatomy as a potential biomarker of persistent pain after total knee replacement in osteoarthritis
27. Brain gray matter abnormalities in osteoarthritis pain: a cross-sectional evaluation
28. Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction
29. Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results of a Randomized, Placebo-Controlled Pilot Trial
30. Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons
31. Prediction of post-surgical disability in knee osteoarthritis patients
32. Physical function status in hip and knee osteoarthritis: pain, psychological features and functional capacity play a major role
33. A Two-Step, Trajectory-Focused, Analytics Approach to Attempt Prediction of Analgesic Response in Patients with Moderate-to-Severe Osteoarthritis
34. The Burden of Long-Term Opioid Use on Emotional, Cognitive and Sensorimotor Domains in Chronic Back Pain
35. The mechanical consequence of actual bone loss and simulated bone recovery in acute spinal cord injury
36. Brain and psychological determinants of placebo pill response in chronic pain patients
37. Brain white matter structural properties predict transition to chronic pain
38. Effect of Parathyroid Hormone Combined With Gait Training on Bone Density and Bone Architecture in People With Chronic Spinal Cord Injury
39. Torsional stiffness and strength of the proximal tibia are better predicted by finite element models than DXA or QCT
40. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain
41. Bone Imaging and Fracture Risk after Spinal Cord Injury
42. Calcaneal Quantitative Ultrasound Compared With Hip and Femoral Neck Dual-Energy X-Ray Absorptiometry in People With A Spinal Cord Injury
43. WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee
44. Additional file 1 of Factors associated with physician-reported treatment status of patients with osteoarthritis pain
45. Pain Characteristic Differences Between Subacute and Chronic Back Pain
46. Prevalence of 25-Hydroxyvitamin D Deficiency in the Acute Inpatient Rehabilitation Population and Its Effect on Function
47. Effects of Naproxcinod on Blood Pressure in Patients With Osteoarthritis
48. Bone Mineral Loss at the Distal Femur and Proximal Tibia Following Spinal Cord Injury in Men and Women
49. Intra-articular hylastan versus steroid for knee osteoarthritis
50. Response to Singhania and Bhattacharya
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.